Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.53 EUR | +0.14% |
|
+4.19% | +5.76% |
Jul. 01 | Orion, Merck & Co. Convert Agreement into Exclusive Global License to Opevesostat | MT |
Jul. 01 | Orion Upgrades FY24 Outlook After Modifying Agreement with Merck & Co | MT |
- Stock Market
- Equities
- ORNBV Stock
- News Orion Oyj